Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Tweet this
Print
Katarzyna A. Juszczak-Kosela, MD (she/her/hers)
Clinician
Pfizer Inc, Poland
Poster(s):
(P 323) PHASE 2 STUDY TO EVALUATE PALBOCICLIB (IBRANCEĀ®) IN COMBINATION WITH IRINOTECAN AND TEMOZOLOMIDE IN PEDIATRIC PATIENTS WITH RECURRENT OR REFRACTORY EWING SARCOMA.